Form 4 for ANIX Anixa Biosciences Inc
Accepted 2026-06-17 11:21:16 ET · period of report 2026-06-16 · accession 0001493152-26-029030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 11:21 | 2026-06-16 | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $2.64 | +2,836 | 972.2K | +0.3% | +$7,487 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-16 | P | A | 2,836 | $2.64 | 972,170 | D | — | — |